SUBSCRIBE NOW
Join our
subscribers!
LATEST PSYCHEDELICS STOCKS NEWS
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
COMPASS PathwaysLONDON, Aug. 04, 2022 --Highlights:Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under reviewCOMP360 phase II study in anorexia nervosa launchedCash position at 30 June 2022 of $207.2 millionConference call today at 8:00am ET (1:00pm UK)COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”... Read More...
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock Market and Toronto Stock Exchange. TORONTO, Aug. 04, 2022 -- Field Trip Health Ltd. (TSX:... Read More...
33 views4 min read
Delic Completes Offering Of Debentures
VANCOUVER, BC, July 29, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units (the "Units") at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022 (the "Clo... Read More...
34 views4 min read
HAVN Life Announces a 30:1 Consolidation of its Common Shares
VANCOUVER, British Columbia, July 29, 2022 -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company” or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (“Consolida... Read More...
116 views3 min read
Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine
Silo shows reversal of allodynia and hyperalgesia using its selected formulation and partnered, patented delivery system ENGLEWOOD CLIFFS, N.J, July 27, 2022 -- Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announced that its topically administered Ketamine reached a positive end point in an animal ... Read More...
COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022
COMPASS PathwaysLONDON, July 26, 2022 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2022, and provide an update on recent business developments on 4 Au... Read More...
101 views8 min read
Delic 2021 Revenue Shows Strong Growth as Nation’s Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services
Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon
KWC, Serving the Most Patients in the U.S., Adds NAD+ Therapy and Launches Ketamine Wellness Integrated Therapist Directory
VANCOUVER, BC, July 21, 2022 - Delic Holdings Corp ("DELI... Read More...
108 views5 min read
Field Trip Announces First Dosings in Phase I Clinical Study of FT-104
- First Dosings completed in Australia- Provides Update on Pending Spin-Out and Renaming to Reunion Neurosciences- Announces 5:1 Share Consolidation Ratio TORONTO, July 21, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic thera... Read More...
1156 views0 min read
Optimi Health Requests Approval To Manufacture MDMA, Other Synthetic Psychedelics
ReutersFactory shutdown to hit Barry Callebaut after 9-month sales riseZURICH (Reuters) -Barry Callebaut expects a "notable financial impact" in its fourth quarter from the shutdown of its Wieze factory as the world's biggest chocolate maker said on Wednesday that strong demand boosted sales in the nine months to May. Sales volumes grew 7... Read More...
53 views0 min read
Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
1135 views0 min read
Red Light Holland and Superstar Wiz Khalifa to Launch Naturally Occurring Psilocybin and Mushrooms Wellness Brand: Mistercap
ReutersCryptoverse: Holding your breath for a bitcoin bounceBitcoin's slide since May, swamped by economic angst, has knocked it below its 200-week moving average, at around $22,600, as well as its 200-day moving average around $35,500. Valkyrie Investments, for one, says its research is pointing to an upside move - but that it isn't clea... Read More...
39 views4 min read
Delic Labs President and CSO Dr. Markus Roggen Named to Cannabis Scientist Power List for Third Consecutive Year
Under Dr. Roggen's leadership, Delic Labs will transfer their expertise and experience from the cannabis sector to establish itself as the leader in psychedelic research and safety testing. The lab has received Health Canada 56 exemptions for chemistry analytics on psilocybin mushrooms; to perform research and tests on a host of compound... Read More...
Numinus Wellness Inc. Reports Q3 2022 Results
Revenues grew 32% year-over-year to $0.74 million for the quarter
Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior quarter
Achieved 24.4% gross margin and $180,845 gross profit of during Q3 2022
Ended quarter with strong cash position of $41.8 million
Completed acquisition of Novamind, posit... Read More...
231 views8 min read
Allied Corp Successfully Ships Second Commercial Cannabis Flower Export From Colombia to International Market
KELOWNA, British Columbia, July 14, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed its second shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pr... Read More...
876 views4 min read
Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And Research Centre
VANCOUVER, British Columbia, July 13, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics and natural functional and psilocybin mushroom strains for transformational human experiences, is pleased to announce that... Read More...
1043 views2 min read
Silo Pharma Announces Positive Results in Subcutaneous Delivery of its Novel Liposomes to Treat Arthritic Patients
ENGLEWOOD CLIFFS, N.J, July 12, 2022 -- Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announces that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. Eric Weisblum, CEO of Silo Pharma commented “The suc... Read More...
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical
-- Expected to accelerate clinical development pathway of CYB004 for the potential treatment of anxiety disorders by nine months --TORONTO, July 11, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics™", today announc... Read More...
1006 views4 min read
Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe"), a Canadian Biotechnology company committed to discovering and developing psychedelic derived medicines today announced it has developed its initial Phase 1 study plan intended to demonstrate the safety and appropriate dos... Read More...
384 views7 min read
Pure Extracts Provides Q3 Corporate Update
VANCOUVER, British Columbia, July 07, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to provide a brief summary of recent activities. The Summer season has... Read More...
885 views4 min read
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
VANCOUVER, British Columbia, July 07, 2022 -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian pharmaceutical development company, is pleased to provide an update on its planned Phase 1 clinical human study of AP-188 (“N,N-dimethyltryptamine” or “DMT”). DMT ... Read More...
891 views5 min read
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate and Pamoate
VANCOUVER, British Columbia, July 05, 2022 -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to disclose that as part of its intellectual property patent applications filed in early 2021 for AP-188 (“N,N-dimethyltryptami... Read More...
881 views4 min read
Aion Therapeutic Announces Intellectual Property Sale and Management and Board Changes
Toronto, Ontario--(Newsfile Corp. - June 30, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has sold four patent applications and all associated supporting data to Apollon Formularies PLC ("Apollon"), a UK based international pharmaceutical company listed for trading on the Aquis St... Read More...
1064 views3 min read
Pure Extracts Signs Listing Agreement with Shoppers Drug Mart and Receives Initial Purchase Order
VANCOUVER, British Columbia, June 30, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufactur... Read More...
982 views4 min read
Ketamine Wellness Centers (KWC) Launches Ketamine Wellness Integrative Therapist Directory
Nation's Largest Ketamine Therapy Provider Offers Complimentary Patient Resource Supporting Holistic Mental Health Treatment
GILBERT, Ariz., June 30, 2022 - Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), today offic... Read More...
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization
Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies.Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and 228% year over year. Full year patient services revenue was... Read More...
441 views6 min read
Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies
- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.- Closing of the arrangement expected to occur in August.- Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" ... Read More...
1230 views8 min read
Allied Corp Successfully Ships First Commercial Cannabis Flower Export From Colombia to International Market
KELOWNA, British Columbia, June 29, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has completed the first shipment of commercial dried cannabis from Colombia to an international market. On April 01, 2022 Colombia enacted the new legislation allowing for the legal export of dried cannabis pro... Read More...
386 views7 min read
Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity and Equity in Alignment with Measure 109 Regulations
● Red Light Holland launches: 'Red Light. Set. Go!' program to work with exceptional local Oregonians from diverse backgrounds who wish to enter the legal psilocybin service market.● Shunji Smith, Japanese American avid mushroom grower, teacher, and small business owner from Eugene, Oregon joins the program.● Red Light Holland and Halo Co... Read More...
1399 views8 min read
Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA
Optimi Health Corp.Optimi Health Cultivation and Analytical FacilitiesOptimi Health Cultivation and Analytical FacilitiesOptimi Health Fruiting RoomOptimi Health fruiting room being prepared for second grow.VANCOUVER, British Columbia, June 28, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), ... Read More...
905 views3 min read
Pure Extracts Receives Purchase Order for a New Listing of High-Potency Vape Carts from the Ontario Cannabis Store
VANCOUVER, British Columbia, June 28, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...
124 views9 min read
Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting
TORONTO, June 27, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announced that on June 27, 2022, its shareholders approved both the Arrangement Resolution, the Concurrent Financing Resolution and the SpinCo ... Read More...
1279 views5 min read
Numinus Unveils New Logo and Brand Identity
New branding unifies Numinus' presence across North America
Rebranding will be accomplished in phases and completed by end of 2022
VANCOUVER, BC, June 27, 2022 - Numinus Wellness Inc. ("Numinus", the "Company") (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce the launch of a new visual brand identity that will be applied to all Company ... Read More...
107 views4 min read
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization
VANCOUVER, British Columbia, June 27, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that Dr. Alan Kozikowski will no longer serve in... Read More...
866 views2 min read
Silo Pharma Expands License Agreement and Patent Portfolio
Silo Enters into Commercial Evaluation License Agreement for Next Generation Liposomes Therapeutics Would Target Multiple Diseases Including Auto Immune Disorders ENGLEWOOD CLIFFS, N.J., June 23, 2022 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of traditional and psychedelics as a t... Read More...
Delic Corp to Present Vision for Long-Term Growth and Industry-Leading Clinic Developments at First Annual H.C. Wainwright Mental Health Conference
June 27, 2022Held at the Lotte New York Palace Hotel, the inaugural event will feature a full day of company presentations, networking opportunities and one-on-one investor meetings with a focus on neuropsychiatry, psychedelics and more. During this year's conference, Stang will deliver a presentation that highlights the company's strateg... Read More...
73 views3 min read
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
VANCOUVER, British Columbia, June 23, 2022 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that Dr. Ahmad Doroudian, Chief Executive Officer, will p... Read More...
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022
TORONTO, June 23, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip’s Co-founder and Executive Chairman, Ronan Levy, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a live fireside ... Read More...
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET
TORONTO, June 22, 2022 -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal fourth quarter and full year ended March 31, 2022, after market close on Wednesday, June 29,... Read More...
801 views5 min read
HAVN Life To Be Featured On Viewpoint with Dennis Quaid
The segment includes an in-depth interview with HAVN Life CEO, Tim Moore, as well as clips from Chief Psychedelic Officer, Dr. Ivan Casselman, and Chief Research Officer, Alexzander Samuelsson, where they discuss the Company's end-to-end research, extraction, formulation, and delivery of naturally derived psilocybin, and some of the stra... Read More...
571 views4 min read
Numinus Applies for International Patent Filing of Psychedelics Production Process
Filing would offer added protection to IP already submitted to USPTO
VANCOUVER, BC, June 22, 2022 - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that its subsidiary Numinus Bioscience Inc. ... Read More...
Make smarter
investment strategies
with in-depth news reports
Join our subscribers!
By subscribing, you agree to our
Terms and Conditions
We don't spam and we promise to never share your information.